Healthcare organizations face rising costs, tighter regulation, rapid advances in artificial intelligence, and changing expectations from patients and physicians. These affect how hospitals, pharmaceutical companies, medical device companies, and other healthcare organizations evaluate markets, develop products, plan clinical research, and make investment decisions.

Healthcare market research gives you a clearer view of those changes before they affect adoption, access, or revenue. Strong healthcare market research can show:

  • How physicians make treatment decisions
  • What patients experience during care
  • Where clinical trials lose participants
  • How markets differ across regions
  • Which new technologies are likely to change established practices

I. The New Economic Environment

Rising costs impact every aspect of the healthcare industry, from hospitals having to pay more for labor and operating expenses to pharmaceutical companies facing scrutiny around drug pricing and access.

These financial pressures change what healthcare organizations need from market research. It increasingly needs to answer practical questions about access, adoption, reimbursement, affordability, and treatment behavior.

  • Will patients start and continue treatment at the expected cost?
  • How will physicians respond to formulary or reimbursement restrictions?
  • Which outcomes influence hospital and payer decisions?
  • How does price affect adoption across patient groups?
  • Where do patients leave the treatment process?
  • How do employers and insurers evaluate the financial case for a new therapy?

Is Healthcare Market Research Becoming More Litigious for Hospitals, Physicians, and Patients?

Healthcare organizations face greater legal exposure around privacy, cybersecurity, data sharing, artificial intelligence, and patient consent, particularly in the United States. These legal risks vary by country due to the differences in patient protections and other regulations.

The U.S. Healthcare Environment Compared to the European Union, Latin America, APAC, and the Middle East

A global healthcare research study can no longer assume that one research design will translate properly across markets. Financing systems, privacy rules, clinical practice, digital adoption, treatment access, and research infrastructure vary substantially.

The United States

Cost and access to healthcare have a disproportionately large influence on behavior due to the several layers between treatment decisions and patient access, such as:

  • High costs
  • Employer-sponsored insurance
  • Medicare and Medicaid
  • Commercial insurers
  • Pharmacy benefit managers
  • Provider networks

Healthcare market research in the United States often needs to separate physician, patient, payer, and health system components.

European Union

The European Health Data Space Regulation began on March 5th, 2025. It creates a framework for patients to access and control electronic health information while allowing the secure secondary use of health data for research, policy, regulatory work, and other approved purposes.

For healthcare market research firms, the European Health Data Space could broaden access to health data while placing greater weight on governance, permitted uses, data security, and cross-border research design.

Latin America and the Caribbean

Financing remains a defining research variable in these markets. The Pan American Health Organization reported in December 2025 that public expenditure accounted for 55.6% of healthcare resources in Latin America and the Caribbean in 2023. Out-of-pocket spending accounted for 1/3 of healthcare expenditure.

Research on treatment adoption in these markets needs to account for affordability at the household level as well as national and private coverage. Findings from higher-income markets may produce poor and inaccurate forecasts when patients face substantially different payment burdens.

Asia-Pacific

China has become far more important to global pharmaceutical research. IQVIA data reported by Reuters found that Chinese companies accounted for 32% of clinical trials in 2025, up from 2% in 2009.

Middle East

Saudi Arabia is increasing its clinical research activities. The Saudi Food and Drug Authority reported an 83% increase in clinical trial applications for advanced therapies and biotechnology products during 2025. Research in the Middle East requires country-level treatment, as the healthcare markets vary dramatically from country to country.

II. New Market Research Trends

Healthcare research now draws on a wider range of data and research methods, including interviews, focus groups, surveys, and central location studies.

  • Hospital research increasingly combines clinical, operational, financial, and patient evidence through electronic health records, claims data, and patient research
  • Current physician market research explores how the rapid adoption of AI by physicians impacts workflow, evidence standards, liability, patients, interoperability, and efficiency
  • Patient research is moving closer to actual behavior with digital health tools, portals, wearables, and patient-reported outcomes, making segmentation increasingly important
  • In clinical trials, patient recruitment research evaluates practical questions about participation, trial adherence, and trust

III.  The Impact of AI on Traditional Healthcare Research Market Research

AI already accelerates several parts of healthcare research, including:

  • Summarizing large text datasets
  • Assisting with qualitative coding
  • Supporting questionnaire development
  • Helping researchers examine large volumes of unstructured feedback

The Impact of AI on Clinical Trials

Clinical trials require tight controls for source quality, privacy, bias, and validation. The research question should be where AI belongs in the process. Patient recruitment offers one measurable example where using AI could save time without sacrificing accuracy.

The Impact of AI on Pharmaceutical Company Research

Eli Lilly and Nvidia announced in January 2026 that they would spend $1 billion over five years on a joint research laboratory using AI for biotechnology and drug development. Lilly had already announced an Nvidia-powered supercomputer in October 2025 for training drug discovery models on millions of experiments.

Traditional pharmaceutical market research will remain a part of this work because algorithms do not eliminate commercial questions about physician adoption, treatment preferences, unmet patient needs, pricing, access, competitors, communication, and behavior.

IV.  Expectations from Healthcare Research

Clients and research participants ask more from healthcare studies today. While speed is important, so is confidence in the source and method. Expectations can vary based on the type of research:

  • Pharmaceutical firms increasingly need research that connects the clinical and commercial sides of development, including treatment pathway research, physician and patient segmentation, pricing and access research, competitor monitoring, and clinical trial recruitment research
  • Physicians expect research to respect their time and clinical experience, with particular considerations for workflow and adoption decisions
  • Patients expect convenience, transparency, privacy, and a clearer explanation of how their information will be used

V. Future Trends

Healthcare market research is likely to become more closely connected to clinical data, real-world evidence, regulatory work, and continuing patient feedback. Differences among countries will remain large enough that global studies will need strong local research design.

  • Pharmaceutical research will increasingly combine several evidence streams throughout the product lifecycle
  • Physicians will expect evidence that new technologies save time, work inside existing clinical systems, protect patient data, and support clinical judgment
  • Patients will have access to more information, more digital tools, and more ways to generate their own health data

Frequently Asked Questions About Trends in Healthcare Market Research

How do hospitals use market research to make better decisions?

Hospitals rely on healthcare market research firms to study patient needs, service demand, physician behavior, competitor activity, patient experience, and gaps in care. Research can help hospitals:

  • Decide where to add services
  • Improve patient access
  • Revise communication
  • Invest in a new technology

What should healthcare companies look for in a market research firm?

Healthcare companies should look for a market research firm with experience recruiting physicians, patients, payers, hospital leaders, and other specialized healthcare audiences. The firm should also have clear procedures for privacy, consent, data security, research quality, and compliance when studies involve protected health information.

How can healthcare market research reduce risk before launching a new product?

Before an organization commits heavily to a launch, healthcare market research can test:

  • Demand
  • Treatment preferences
  • Pricing
  • Access barriers
  • Physician interest
  • Patient needs
  • Likely adoption

In conclusion, we recommend an ongoing tracking and monitoring systems of the changing trends in healthcare and the impact on your business.